Firebrick Secures $1.5 million via Placement
Filed with ASX · · 4 pages · English
Firebrick Pharma Limited on 6ix
Story so far
Earlier from Firebrick Pharma
- Trading Halt
- Registration Agreement and Approval of Nasodine in Indonesia
- Appendix 4D & Half-Year Financial Report to 31 December 2025
- December 2025 Quarterly Activity Report & Appendix 4C
- Nasodine Throat Spray Product Launch in Singapore
Later from Firebrick Pharma
- March 2026 Quarterly Activity Report & Appendix 4C
- Investor Update
- Appendix 4E and Annual Report 30 June 2026
- Firebrick receives $293,000 R&D Tax Incentive
- Firebrick announces USA Retail Launch Plan
Follow Firebrick Pharma into a list and get an email when it puts out news.
Follow Firebrick Pharma